MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$371,630K
Marketable securities
$166,854K
Prepaid expenses and
other current assets
$5,456K
Total property and
equipment
$21,492K
Total current assets
$543,940K
Property and equipment,
net
$15,295K
Operating lease right-of
use assets
$12,816K
Other assets
$3,601K
Restricted cash
equivalents
$1,149K
Less accumulated
depreciation and...
$6,197K
Total assets
$576,801K
Total liabilities,
redeemable convertible...
$576,801K
Total stockholders'
equity (deficit)
$506,108K
Total liabilities
$70,693K
Accumulated deficit
-$174,889K
Accumulated other
comprehensive (loss) income
-$241K
Additional paid-in capital
$681,233K
Deferred revenue, net of
current portion
$32,633K
Total current
liabilities
$27,913K
Operating lease
liabilities, net of current...
$10,147K
Common stock
value-Common Stock
$5K
Deferred revenue,
current portion
$18,958K
Accrued expenses and
other current...
$6,298K
Operating lease
liabilities, current portion
$1,430K
Accounts payable
$1,227K
Back
Back
Balance Sheet
Aktis Oncology, Inc. (AKTS)
Aktis Oncology, Inc. (AKTS)
source: myfinsight.com